Historical Stock Price
DBVT historical stock prices picture
DBV Technologies Boulogne-Billancourt (DBVT) has the following price history information. Looking back at DBVT historical stock prices for the last five trading days, on April 22, 2024, DBVT opened at $0.66, traded as high as $0.72 and as low as $0.65, and closed at $0.66. Trading volume was a total of 43.40K shares. On April 23, 2024, DBVT opened at $0.69, traded as high as $0.71 and as low as $0.66, and closed at $0.68. Trading volume was a total of 117.00K shares. On April 24, 2024, DBVT opened at $0.71, traded as high as $0.71 and as low as $0.67, and closed at $0.69. Trading volume was a total of 2.60K shares. On April 25, 2024, DBVT opened at $0.68, traded as high as $0.71 and as low as $0.66, and closed at $0.69. Trading volume was a total of 40.90K shares. On April 26, 2024, DBVT opened at $0.69, traded as high as $0.71 and as low as $0.66, and closed at $0.68. Trading volume was a total of 41.60K shares.

DBVT Historical Stock Prices By Date:

DBVT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into DBV Technologies Boulogne-Billancourt shares, starting with a $10,000 purchase of DBVT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/23/2014
End date: 04/26/2024
Start price/share: $28.50
End price/share: $0.68
Dividends collected/share: $0.00
Total return: -97.61%
Average Annual Total Return: -32.45%
Starting investment: $10,000.00
Ending investment: $239.26
Years: 9.52
Date Open High Low Close Volume
04/22/2024 $0.66 $0.72 $0.65 $0.66 43.40K
04/23/2024 $0.69 $0.71 $0.66 $0.68 117.00K
04/24/2024 $0.71 $0.71 $0.67 $0.69 2.60K
04/25/2024 $0.68 $0.71 $0.66 $0.69 40.90K
04/26/2024 $0.69 $0.71 $0.66 $0.68 41.60K
DBV Technologies is a clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Viaskin™. Co.'s therapeutic approach is based on epicutaneous immunotherapy, or EPIT™, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin™. Co.'s lead product candidate, Viaskin™ Peanut, has completed a global Phase III program for the treatment of peanut-allergic patients four to 11 years of age. Co.'s second product candidate, Viaskin™ Milk, is in development for the treatment of cow's milk protein allergy children two to 17 years of age.
Date Close
04/22/2024$0.66
04/23/2024$0.68
04/24/2024$0.69
04/25/2024$0.69
04/26/2024$0.68

DBVT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.